A recent study has shown that t(6;9) AML displays a gene expression signature reminiscent of other AML subtypes, such as NPM1-mutated patients, which is characterized by the overexpression of HOX genes, a key leukemia driver event [8]. Here, NPM1 is linked to acute myeloid leukemia.